Literature DB >> 24345733

Sleep duration, but not insomnia, predicts the 2-year course of depressive and anxiety disorders.

Josine G van Mill1, Nicole Vogelzangs, Eus J W van Someren, Witte J G Hoogendijk, Brenda W J H Penninx.   

Abstract

OBJECTIVE: To examine the predictive role of insomnia and sleep duration on the 2-year course of depressive and anxiety disorders.
METHOD: This study is a secondary data analysis based on data from the baseline (2004-2007) and 2-year assessment of the Netherlands Study of Depression and Anxiety. Participants were 1,069 individuals with DSM-IV-based depressive and/or anxiety disorders at baseline. Sleep measures included insomnia (Women's Health Initiative Insomnia Rating Scale score ≥ 9) and sleep duration (categorized as short [≤ 6 hours], normal [7-9 hours], or long [≥ 10 hours]). Outcome measures were persistence of DSM-IV depressive and anxiety disorders (current diagnosis at 2-year follow-up), time to remission, and clinical course trajectory of symptoms (early sustained remission, late remission/recurrence, and chronic course). Logistic regression analyses were adjusted for sociodemographic characteristics and chronic medical disorders, psychotropic medications, and severity of depressive and anxiety symptoms.
RESULTS: The effect of insomnia on persistence of depressive and/or anxiety disorders (OR = 1.50; 95% CI, 1.16-1.94) was explained by severity of baseline depressive/anxiety symptoms (adjusted OR with severity = 1.04; 95% CI, 0.79-1.37). Long sleep duration was independently associated with persistence of depression/anxiety even after adjusting for severity of psychiatric symptoms (OR = 2.52; 95% CI, 1.27-4.99). For short sleep duration, the independent association with persistence of combined depression/anxiety showed a trend toward significance (OR = 1.32; 95% CI, 0.98-1.78), and a significant association for the persistence of depressive disorders (OR = 1.49; 95% CI, 1.11-2.00). Both short and long sleep duration were independently associated with a chronic course trajectory (short sleep: OR = 1.50; 95% CI, 1.04-2.16; long sleep: OR = 2.91, 95% CI, 1.22-6.93). DISCUSSION: Both short and long sleep duration-but not insomnia-are important predictors of a chronic course, independent of symptom severity. It is to be determined whether treating these sleep conditions results in more favorable outcomes of depression and anxiety. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24345733     DOI: 10.4088/JCP.12m08047

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  26 in total

1.  Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the Recommended Amount of Sleep for a Healthy Adult: Methodology and Discussion.

Authors:  Nathaniel F Watson; M Safwan Badr; Gregory Belenky; Donald L Bliwise; Orfeu M Buxton; Daniel Buysse; David F Dinges; James Gangwisch; Michael A Grandner; Clete Kushida; Raman K Malhotra; Jennifer L Martin; Sanjay R Patel; Stuart F Quan; Esra Tasali
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

2.  Sleep Duration and Insomnia Symptoms as Risk Factors for Suicidal Ideation in a Nationally Representative Sample.

Authors:  Subhajit Chakravorty; H Y Katy Siu; Linden Lalley-Chareczko; Gregory K Brown; James C Findley; Michael L Perlis; Michael A Grandner
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-31

3.  Socioeconomic disparities in sleep duration among veterans of the US wars in Iraq and Afghanistan.

Authors:  Rachel Widome; Agnes Jensen; Steven S Fu
Journal:  Am J Public Health       Date:  2015-02       Impact factor: 9.308

4.  Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the Recommended Amount of Sleep for a Healthy Adult: Methodology and Discussion.

Authors:  Nathaniel F Watson; M Safwan Badr; Gregory Belenky; Donald L Bliwise; Orfeu M Buxton; Daniel Buysse; David F Dinges; James Gangwisch; Michael A Grandner; Clete Kushida; Raman K Malhotra; Jennifer L Martin; Sanjay R Patel; Stuart F Quan; Esra Tasali
Journal:  Sleep       Date:  2015-08-01       Impact factor: 5.849

5.  Soybeans or Soybean Products Consumption and Depressive Symptoms in Older Residents in Rural Northeast China: A Cross-Sectional Study.

Authors:  S Yu; X Guo; H Yang; L Zheng; Y Sun
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

6.  Sleep disturbance and physiological regulation among young adults with prior depression.

Authors:  Jessica L Hamilton; Jonathan P Stange; Taylor A Burke; Peter L Franzen; Lauren B Alloy
Journal:  J Psychiatr Res       Date:  2019-05-16       Impact factor: 4.791

7.  Sleep Disturbances and Depression in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Carmela Alcántara; Mary L Biggs; Karina W Davidson; Joseph A Delaney; Chandra L Jackson; Phyllis C Zee; Steven J C Shea; Susan Redline
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

8.  Sleep Duration Associated with the Lowest Risk of Depression/Anxiety in Adolescents.

Authors:  Yasutaka Ojio; Atsushi Nishida; Shinji Shimodera; Fumiharu Togo; Tsukasa Sasaki
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

9.  Association of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon Treatment.

Authors:  Megan M Marron; Stewart J Anderson; Jessica Garrity; Charles F Reynolds; Francis E Lotrich
Journal:  Psychosom Med       Date:  2015-10       Impact factor: 4.312

10.  Dyadic effects of distress on sleep duration in advanced cancer patients and spouse caregivers.

Authors:  Amy K Otto; Brian D Gonzalez; Richard E Heyman; Susan T Vadaparampil; Lee Ellington; Maija Reblin
Journal:  Psychooncology       Date:  2019-11-12       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.